查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2049347

即時診斷市場規模、佔有率、趨勢和預測：按產品類型、平台、處方模式、最終用戶和地區分類，2026-2034 年

Point-of-Care Diagnostics Market Size, Share, Trends and Forecast by Product Type, Platform, Prescription Mode, End-User, and Region, 2026-2034
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3個工作天內

價格

2025年全球即時診斷市場規模為571億美元。展望未來，IMARC Group預測，該市場將以7.27%的複合年成長率從2026年成長至2034年，到2034年達到1,095億美元。截至2025年，北美市場佔據主導。推動市場成長的主要因素包括：對更快、更便捷的診斷解決方案的需求不斷成長、感染疾病在全球範圍內的蔓延以及技術進步和小型化。

全球市場的主要驅動力是慢性病和感染疾病的蔓延，這需要快速、準確的診斷解決方案來有效管理。此外，緊急情況和偏遠地區對快速檢測套組的需求不斷成長，推動了即時診斷技術的應用，從而提高了醫療服務的可近性。同時，生物感測器和微流體技術等先進技術的整合，簡化了診斷流程，提高了效率和可靠性，也推動了市場的發展。醫療基礎設施的持續改進，以及對早期疾病檢測以便及時介入的日益重視，也提振了市場前景。此外，對創新診斷解決方案研發投入的增加，也促進了即時診斷技術的發展。診斷領域對數位化平台和互聯互通的需求不斷成長，也促進了數據管理，最終改善了患者的整體治療效果。最後，即時診斷技術在腫瘤學、心臟病學和感染疾病管理等領域的廣泛應用，也推動了該市場的成長。

美國作為主要區域市場脫穎而出，其成長主要受慢性病和感染疾病在人群中日益普遍的推動。家用和攜帶式檢測設備需求的快速成長也透過提升患者便利性推動了即時診斷市場的發展。此外，人工智慧和生物感測器等先進技術在診斷領域的日益普及，正在簡化流程，提高準確性和效率，從而為市場創造了巨大的發展機會。同時，旨在促進創新並擴大產品在所有醫療機構中應用的前瞻性監管政策也在推動市場成長。截至2024年2月22日，美國食品藥物管理局（FDA）的診斷數據項目啟動了一項旨在支持開發創新方法的計劃，用於收集、協調、傳輸和分析來自傳統檢查室之外的檢測診斷數據。該計劃預計將整合實驗室內外收集的數據流，有助於改善公共衛生決策。與美國國立衛生研究院 (NIH) 的 ITAP 和 RADx 計畫等聯邦機構的策略合作，也正在推動標準化評估方案和數據報告機制的製定，從而加速家庭檢測的核准。此外，醫療基礎設施投資的增加顯著擴大了先進診斷解決方案的覆蓋範圍，進而推動了市場成長。

即時診斷市場趨勢：

慢性病盛行率增加

世界衛生組織（世衛組織）的數據顯示，非傳染性疾病（也稱為慢性病）每年奪走4,100萬人的生命，佔全球死亡總數的74%。同樣，愛滋病等感染疾病仍然是重大的健康挑戰。世衛組織估計，到2022年，全球將有3,900萬人感染愛滋病毒，當年新增感染病例約130萬例。全球慢性病的日益增加推動了對即時診斷（POC）服務的需求。糖尿病、心血管疾病和呼吸系統疾病等慢性病在一般人群中日益普遍，為全球醫療保健系統帶來了嚴峻挑戰。即時診斷為即時檢測和持續監測這些健康併發症提供了一種寶貴的工具，從而能夠及時介入並有效管理疾病。即時檢測的便利性和可近性進一步促進了慢性病的管理，尤其是在傳統檢測設施有限或無法獲得的偏遠農村地區。

各種技術進步

技術創新和整合在推動即時診斷市場成長方面發揮著至關重要的作用。小型化、生物感測器和互聯互通的努力和研究正在催生各種智慧型攜帶式診斷設備和系統。這些即時診斷設備能夠以高精度執行多種檢測，而這通常是傳統檢查室方法無法實現的。在許多情況下，它們還提供更豐富的檢測項目，減少對多種設備的需求，並縮短獲得檢測結果的時間。例如，2023年2月，Huwel Lifesciences公司開發了攜帶式RT-PCR設備，可以檢測多種病毒。據該公司稱，該檢測大約需要30分鐘，可以使用血液和胃腸檢體識別感染疾病和其他感染疾病。同樣，2020年，雅培公司推出了“ID NOW”，這是世界上速度最快的分子即時診斷檢測。該設備僅需13分鐘即可提供新冠病毒檢測結果。該設備已廣泛應用於診所和急診室等分散式醫療機構。 2023年5月，丹納赫公司發布了“Dxl 9000 Access免疫分析儀”，該設備每小時可完成多達215項檢測，顯著擴展了該公司即時檢測（POC​​）診斷產品線。其他公司也計劃生產體積小巧、功能全面的即時檢測系統。主要市場參與者正與其他公司合作，提供獨特可靠的診斷解決方案，以革新醫療保健服務。 2023年，Molbio Diagnostics宣布與SigTuple合作，共同開發用於各種常規和診斷測試的下一代人工智慧行動裝置。

人們對個人化醫療的興趣日益濃厚

公眾對個人化醫療日益成長的需求正在推動市場成長。美國國家癌症研究所 (NCI)推出大規模的精準醫療癌症舉措，旨在檢驗多種新型藥物組合在兒童和成人中的治療效果。此外，隨著醫療保健行業向以患者為中心的模式轉變，個人化醫療的日益普及正在促進針對個別患者需求量身定做的治療方案的發展。世界衛生組織 (WHO) 的數據顯示，2020 年各國政府的醫療保健支出在各個收入階層均大幅成長，全球醫療保健支出達到創紀錄的 9 兆美元，約佔全球 GDP 的 11%。投資的成長反映出人們對包括精準醫療在內的先進醫療解決方案的日益關注。即時診斷 (POC) 在此過程中發揮著至關重要的作用，它能夠提供快速且準確的診斷解決方案，並支援精準的疾病識別和監測。這些優勢讓患者對自身的治療和整體健康狀況感到安心，因此備受患者支持。此外，Coriell Life Sciences 的研究也證實，精準醫療的普及應用已在全球迎來轉捩點。

目錄

第1章：序言

第2章：調查方法

  • 調查目的
  • 相關利益者
  • 數據來源
    • 主要訊息
    • 次要訊息
  • 市場估值
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章執行摘要

第4章：引言

第5章：全球即時診斷市場

  • 市場概覽
  • 市場表現
  • 新冠疫情的影響
  • 市場預測

第6章 市場區隔：依產品類型分類

  • 血糖值監測套件
  • 心臟代謝監測套件
  • 妊娠及不孕症檢測套組
  • 傳染病檢查試劑盒
  • 膽固醇試紙
  • 血液檢測套組
  • 其他

第7章 市場區隔：依平台分類

  • 橫向流動化驗
  • 油尺
  • 微流體
  • 分子診斷
  • 免疫檢測

第8章 市場細分：依處方類型分類

  • 處方箋檢測
  • 非處方藥檢測

第9章 市場區隔：依最終用戶分類

  • 專業診斷中心
  • 居家照護
  • 研究所
  • 其他

第10章 市場區隔：依地區分類

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲

第11章 SWOT 分析

第12章：價值鏈分析

第13章：波特五力分析

第14章 價格指標

第15章 競爭格局

  • 市場結構
  • 大公司
  • 主要公司簡介
    • Abbott Laboratories
    • Beckman Coulter Inc.
    • Becton, Dickinson and Company
    • F. Hoffmann-La Roche AG
    • Instrumentation Laboratory
    • Johnson & Johnson
    • Nova Biomedical Corporation
    • Pts Diagnostics
    • Qiagen
    • Siemens
    • Trinity Biotech
Product Code: SR112026A2113

The global point-of-care diagnostics market size was valued at USD 57.1 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 109.5 Billion by 2034, exhibiting a CAGR of 7.27% during 2026-2034. North America currently dominates the market in 2025. The increasing demand for faster and more convenient diagnostic solutions, rising prevalence of infectious diseases across the globe, and advancements in technology and miniaturization represent some of the key factors driving the market.

The global market is majorly driven by the prevalence of chronic and infectious diseases requiring faster and accurate diagnostic solutions for effective management. In addition to this, increasing demand for rapid testing kits in emergency and remote settings is augmenting the adoption of point-of-care diagnostics, thereby promoting the accessibility of healthcare services. Furthermore, the integration of sophisticated technologies, including biosensors and microfluidics, into the processes for streamlining diagnosis, resulting in increased efficiency and reliability, is propelling the market. Moreover, continual improvements the healthcare infrastructure, along with an increasing focus on early detection of diseases for timely intervention, are creating a positive market outlook. Besides this, research and development (R&D) expenditures for innovative diagnostic solutions are encouraging the growth in point-of-care technologies. The increasing demand for digital platforms and connectivity in diagnostics is also making it easier to manage data and consequently improving overall outcomes for the patient. Furthermore, the increased applications of point-of-care diagnostics in such areas as oncology, cardiology, and infectious disease management have strengthened the growth of this market.

The United States stands out as a key regional market, driven by the increasing prevalence of chronic and infectious diseases among the masses. Besides, the accelerating demand for home-based and portable testing devices is also propelling the point-of-care diagnostics market by facilitating greater patient convenience. Also, the increasing usage of advanced technologies such as AI and biosensors in diagnostics has streamlined the process and helped in better accuracy and efficiency, which is creating lucrative opportunities in the market. In addition, positive regulatory policies driving innovation and increasing the availability of products in all healthcare settings is impelling the market. As of February 22, 2024, the FDA's Diagnostic Data Program launched an initiative that aimed to support the development of innovative methods for collecting, harmonizing, transmitting, and analyzing diagnostic data from tests performed outside traditional laboratories. This will help integrate non-laboratory-based data streams with lab-based ones to improve public health decision-making. Also, strategic collaborations with federal agencies, such as NIH's ITAP and RADx programs, are facilitating the authorization of at-home tests by developing standardized evaluation protocols and data reporting mechanisms. Furthermore, increased investments in healthcare infrastructure is significantly expanding access to sophisticated diagnostic solutions, which is driving market growth.

POINT-OF-CARE DIAGNOSTICS MARKET TRENDS:

The Growing Prevalence of Chronic Diseases

According to the World Health Organization (WHO), non-communicable diseases, also called chronic diseases, kills 41 million people each year, which is equivalent to 74% of all deaths globally. Similarly, infectious diseases such as HIV remain a major health challenge, with an estimated 39.0 million people living with HIV in 2022 and approximately 1.3 million acquiring the infection globally that year, according to WHO. The global rise in chronic diseases is driving the demand for POC diagnostic services. Chronic conditions, such as diabetes, cardiovascular diseases, and respiratory disorders, are becoming increasingly prevalent among the masses, posing substantial challenges to healthcare systems worldwide. POC diagnostics offer a valuable tool for spontaneous detection and continuous monitoring of these health complications, facilitating timely interventions and effective disease management. The convenience and easy availability of POC testing further contributes to the management of chronic diseases, especially in remote or rural areas where access to traditional laboratory facilities is limited or not available.

Various Technological Advancements

Technological innovations and integration play a crucial role in supporting the point-of-care diagnostics market growth. Initiatives and research in miniaturization, biosensors, and connectivity are leading to the creation of various smart and portable diagnostic devices and systems. These POC devices can perform a wide range of tests with high accuracy, which traditional laboratory-based methods often fail to deliver. They are also often integrated with expanded test menus to eliminate the need for multiple devices and reduce turnaround time for getting the test results. For instance, in February 2023, Huwel Lifesciences developed a portable RT-PCR device that can test multiple viruses. The company stated the test takes about 30 minutes and can identify respiratory and other infections using blood and gastrointestinal samples. Similarly, Abbott launched ID NOW in 2020, which is the world's fastest molecular POC test. It delivers COVID-19 results in just 13 minutes. This device is widely used in dispersed healthcare settings such as doctor's offices and urgent care clinics. In May 2023, Danaher Corporation introduced the Dxl 9000 Access Immunoassay Analyzer, capable of running up to 215 tests per hour, significantly expanding the company's POC diagnostics offerings. Companies are also planning to produce POC diagnostics systems which are compact in size and offer comprehensive testing facilities. Key market players are also collaborating with other firms to offer unique and reliable diagnostic solutions to revolutionize healthcare delivery. Molbio Diagnostics declared its partnership with SigTuple in 2023 to develop next-generation AI-enabled portable devices for many routine and diagnostic tests.

The Growing Emphasis on Personalized Medicine

The increasing need for personalized medicine among the masses is propelling the growth of the market. The National Cancer Institute (NCI) has launched a large precision medicine cancer initiative to examine the effectiveness of treating children and adults with various novel drug combinations. Moreover, as the healthcare sector is transitioning towards a more patient-centric approach, the acceptance of personalized medicine is facilitating the creation of treatment plans according to the needs of patients. The World Health Organization (WHO) reported that sharp increases in government spending on health at all income levels in 2020 underpinned a rise in global health expenditure to a new high of USD 9 Trillion, accounting for approximately 11% of global GDP. This increase in investment reflects the growing focus on advanced healthcare solutions, including precision medicine. POC diagnostics play a pivotal part in this procedure as it offers rapid and targeted diagnostic solutions that aid in precise disease identification and monitoring. They provide a sense of assurance to patients regarding their treatment and overall wellbeing, which is also responsible for their high acceptance among patients. Moreover, according to research done by Coriell Life Sciences, it is confirmed that precision medicine has reached a global tipping position for adoption.

POINT-OF-CARE DIAGNOSTICS INDUSTRY SEGMENTATION:

Analysis by Product Type:

  • Blood-Glucose Monitoring Kit
  • Cardio-Metabolic Monitoring Kit
  • Pregnancy and Fertility Testing Kit
  • Infectious Disease Testing Kit
  • Cholesterol Test Strip
  • Hematology Testing Kit
  • Others

Blood- glucose monitoring kit leads the market in 2025. Blood-glucose monitoring kits are designed to be user-friendly, allowing patients to perform tests themselves without the need for specialized medical training. The simplicity and convenience of these kits are contributing to their widespread adoption, making them accessible to a broad spectrum of patients, including those in remote or underserved areas. Moreover, blood-glucose monitoring kits are often compact and portable, enabling patients to carry them wherever they go, thereby offering a favorable point-of-care diagnostics market outlook. Furthermore, based on the predictions and research by the Institute for Health Metrics and Evaluation, global diabetes cases will increase from 529 million to 1.3 billion by 2050. The US Food and Drug Administration cleared the first over the counter (OTC) continuous glucose monitoring system (CGM) in the US -- the Dexcom Stelo Glucose Biosensor System. This will help people with Type 2 diabetes who don't need insulin to track their blood sugar for nonmedical purposes.

Analysis by Platform:

  • Lateral Flow Assays
  • Dipsticks
  • Microfluidics
  • Molecular Diagnostics
  • Immunoassays

Lateral flow assays lead the market in 2025. Lateral flow assays are known for their simplicity and user-friendly design. They are easy to use, requiring minimal training for both healthcare professionals and patients. The test procedure typically involves incorporating a sample such as blood, saliva, and urine to a test strip, and the results are visually interpreted through the appearance of colored lines, eliminating the need for complex laboratory equipment. They offer stability over a wide range of environmental conditions and have a long shelf life. They also require a small sample volume to conduct tests. As a result, various organizations and institutions are investing in the development of advanced lateral flow assays. For instance, iiCON announced in 2021 that it will support Liverpool SME to develop advanced lateral flow tests, which can be performed with and without the addition of the Nano Biosols reagent.

Analysis by Prescription Mode:

  • Prescription-Based Testing
  • OTC Testing

Prescription-based testing leads the market in 2025. Prescription-based testing involves diagnostic tests that require a healthcare professional's order or prescription before they can be performed. These tests often undergo rigorous regulatory approval processes to ensure their safety, efficacy, and accuracy. The involvement of healthcare professionals in prescribing these tests ensures appropriate medical supervision and interpretation of the results, leading to better patient care and treatment decisions. Prescription-based testing is essential for the accurate detection, staging, and monitoring of diseases such as cancer, infectious diseases, cardiovascular disorders, and autoimmune conditions. As per the reports of WHO, over 35 million new cancer cases will arise by 2050. This will further increase the need for prescription-based testing solutions.

Analysis by End-User:

  • Professional Diagnostic Centers
  • Home Care
  • Research Laboratories
  • Others

Professional diagnostics centers lead the market in 2025. Professional diagnostic centers offer a wide range of POC diagnostic tests, catering to various medical specialties and healthcare needs. These centers often have advanced equipment and well-trained personnel, allowing them to perform a diverse set of tests, including blood tests, rapid infectious disease testing, urinalysis, pregnancy tests, and more. The availability of comprehensive testing services makes professional diagnostic centers a preferred choice for both patients and healthcare providers. Moreover, professional diagnostic centers are staffed by qualified healthcare professionals, including medical technologists, clinical laboratory scientists, and physicians. For instance, according to a report by the United Nations Economic and Social Commission for Asia and the Pacific (ESCAP), from 2008 to 2021, the pharmaceutical sector received the largest share of foreign direct investment, totaling USD 32 Billion. This amount notably surpassed the FDI attracted by the medical devices sector, which stood at USD 20 billion, the biotechnology industry (USD 17 billion), and healthcare (USD 10.8 Billion) subsectors. This further increased the number of professional diagnostic centers providing comprehensive healthcare services.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2025, North America accounted for the largest market share. North America has a highly developed healthcare infrastructure with well-established medical facilities, laboratories, and diagnostic centers. The robust healthcare system of the region enables widespread adoption and integration of POC diagnostics into routine medical practice, contributing to their market dominance. Besides this, the high prevalence of chronic diseases, such as diabetes, cardiovascular disorders, and respiratory conditions, is driving the demand for comprehensive testing services. POC diagnostics play a crucial role in the early detection, monitoring, and management of these chronic conditions. For instance, as per a press release by the Centers for Disease Control and Prevention, the number of Americans with diabetes will range between 1 in 3 to 1 in 5 by 2050. This will further increase the demand for point-of-care testing solutions in the region.

KEY REGIONAL TAKEAWAYS:

UNITED STATES POINT-OF-CARE DIAGNOSTICS MARKET ANALYSIS

The increasing cancer incidence in the United States is a strong growth factor for the point-of-care diagnostics market in the country. Early detection of cancer improves patient outcomes and the demand for advanced diagnostic solutions is on the rise. According to Cancer.org 2021 data, approximately 1.9 million new cancer cases were diagnosed in the U.S., with 608,570 deaths reported. These alarming statistics call for some innovative diagnostic technologies that should enable timely and accurate disease detection. Moreover, the market leaders have been bringing innovative products due to growing demand for this emerging need. For instance, last October 2022, F. Hoffmann-La Roche Ltd. received its first companion diagnostic, which allows the identification of patients suffering from HER2-low metastatic breast cancer, eligible to receive ENHERTU. This diagnostic breakthrough would mark an important step ahead in cancer care, and it is the role of point-of-care diagnostics that becomes vital in providing patient-specific and targeted solutions. Such innovation will most likely propel the U.S. POC diagnostics market since they respond to the growing need for customized and accurate health care.

EUROPE POINT-OF-CARE DIAGNOSTICS MARKET ANALYSIS

The increasing prevalence of chronic diseases in Europe is a key growth driver for this region's point-of-care diagnostics market. The International Diabetes Federation (IDF) reports that the prevalence of diabetes in the European region is going to increase by 13%. The number of people afflicted with this disease will reach 61 million by 2045. This growing diabetes burden increases the demand for POC diagnostic solutions to monitor glucose levels and manage the disease effectively. Also, cardiovascular diseases (CVD), which are the cause of death in Europe, also drive the POC diagnostics market. The National Institutes of Health reported that CVD accounts for 45% of all deaths in the region, with over 4 million deaths annually, primarily from coronary heart disease and stroke. With a rising incidence of these conditions, there is a need for prompt, on-site diagnostic solutions to detect early, manage, and monitor. POC diagnostics offer an efficient way to address these healthcare challenges, contributing to the market's growth.

ASIA PACIFIC POINT-OF-CARE DIAGNOSTICS MARKET ANALYSIS

One major driving force for the POC diagnostics market in Asia Pacific is the accelerating patients with chronic diseases. Notably, the OECD 2021 states that, out of 227 million people living with type 2 diabetes in the Asia-Pacific region, close to half remain undiagnosed or without realizing their long-term complications. This increase in trend is leading to an escalating demand for early detection and monitoring and thereby propelling the utilization of POC diagnostics. Additionally, the miniaturized diagnostic models and the measures undertaken in hospitals and clinics to reduce the duration of hospital and clinic stay will further propel the demand for POC devices. Moreover, improving health outcomes require accessible and efficient solutions for diagnostics, especially in rural and underserved areas. Also, the market is also being driven by rapid technological advancements, high prevalence of both chronic and infectious diseases, and continuous efforts by local companies and organizations to improve healthcare access. For instance, in January 2023, Cipla Limited launched Cippoint, a POC device capable of testing a wide range of parameters, including diabetes, cardiac markers, fertility, and infectious diseases. This innovation reflects the growing trend of comprehensive, multi-disease diagnostics in the region, further boosting the adoption of POC technologies.

LATIN AMERICA POINT-OF-CARE DIAGNOSTICS MARKET ANALYSIS

This market is gaining momentum in Latin America, primarily due to the increase in prevalence of chronic diseases, along with the growth need for early disease diagnosis. The World Cancer Research Fund International reported that nearly 101,703 cancer cases were diagnosed in Mexico in 2022, which points out the growing demand for appropriate and easily accessible diagnostic devices. POC diagnostics are highly important as early detection of a condition, such as cancer or any other dangerous disease, can lead to positive health outcomes and lessen further health burdens. The rising chronic diseases, including diabetes and cardiovascular diseases, have been stimulating the demand for POC devices as it can offer an immediate and cost-effective diagnosis that results in proper and efficient care of these patients. Also, increasing healthcare technologies and an increase in the awareness levels for preventive health are also significant growth-inducing factors for the market across this region.

MIDDLE EAST AND AFRICA POINT-OF-CARE DIAGNOSTICS MARKET ANALYSIS

The World Heart Federation says that CVD is the leading cause of death in the MENA region, accounting for more than one-third of all deaths or approximately 1.4 million fatalities annually. In 2024, the percentage of CVD deaths varies from country to country in the region, which ranges from 40 percent of total deaths in Oman to 10 percent in Somalia. High prevalence rates of cardiovascular diseases will fuel point-of-care diagnostics growth in Middle East and Africa. POC diagnostics in the management of cardiovascular disease ensure early detection, monitoring, and management of this type of disease, making a timely intervention possible. Growing cardiovascular diseases weigh much on the region. Adoption of POC technologies across the region is likely to gain momentum because of an increasing demand for accessible, rapid, and cost-effective diagnostic solutions. MENA region healthcare systems that have prioritized efficient and preventive care are also going to create an even greater need for POC diagnostics, hence accelerating market growth.

COMPETITIVE LANDSCAPE:

The competitive landscape of the market comprises a wide variety of players, which comprises established companies, emerging startups, and specialized firms. Major players are focusing significant investment on R&D innovation and development of the latest POC diagnostic solutions. Also, they are placing their emphasis on accuracy, sensitivity, and speed of the tests. Top companies expand the range of analytes and diseases detectable by POC devices. R&D activities also encompass the design of innovative technologies, such as biosensors, microfluidics, and systems that are lab-on-a-chip, in pursuit of improving the performance capabilities of POC diagnostics. In addition, they adjust the designs of their products to meet specific health needs and regulatory requirements in various countries. For instance, the company Cipla expanded its product portfolio with the launch of a point-of-care testing device for different forms of non-communicable diseases and other diseases/health conditions. The point-of-care diagnostics market statistics clearly show a very strong growth trajectory, led by higher demands for rapid testing, new technologies, and increasing attention to decentralized healthcare.

The report provides a comprehensive analysis of the competitive landscape in the point-of-care diagnostics market with detailed profiles of all major companies, including:

  • Abbott Laboratories
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • F. Hoffmann-La Roche AG
  • Instrumentation Laboratory
  • Johnson & Johnson
  • Nova Biomedical Corporation
  • Pts Diagnostics
  • Qiagen
  • Siemens
  • Trinity Biotech

Key Questions Answered in This Report

1. What is point-of-care diagnostics?

2. How big is the global point-of-care diagnostics market?

3. What is the expected growth rate of the global point-of-care diagnostics market during 2026-2034?

4. What are the key factors driving the global point-of-care diagnostics market?

5. What is the leading segment of the global point-of-care diagnostics market based on the product type?

6. What is the leading segment of the global point-of-care diagnostics market based on platform?

7. What is the leading segment of the global point-of-care diagnostics market based on prescription mode?

8. What is the leading segment of the global point-of-care diagnostics market based on end-user?

9. What are the key regions in the global point-of-care diagnostics market?

10. Who are the key players/companies in the global point-of-care diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Point-of-Care Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Blood-Glucose Monitoring Kit
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Cardio-Metabolic Monitoring Kit
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Pregnancy and Fertility Testing Kit
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Infectious Disease Testing Kit
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Cholesterol Test Strip
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Hematology Testing Kit
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Others
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast

7 Market Breakup by Platform

  • 7.1 Lateral Flow Assays
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Dipsticks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Microfluidics
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Molecular Diagnostics
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Immunoassays
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Prescription Mode

  • 8.1 Prescription-Based Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 OTC Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Professional Diagnostic Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Care
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Beckman Coulter Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 SWOT Analysis
    • 15.3.3 Becton, Dickinson and Company
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 SWOT Analysis
    • 15.3.5 Instrumentation Laboratory
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 SWOT Analysis
    • 15.3.6 Johnson & Johnson
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Nova Biomedical Corporation
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Pts Diagnostics
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 Qiagen
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
    • 15.3.10 Siemens
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Trinity Biotech
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Point-of-Care Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: Point-of-Care Diagnostics Market: Sales Value (in Billion USD), 2020-2025
  • Figure 3: Global: Point-of-Care Diagnostics Market: Breakup by Product Type (in %), 2025
  • Figure 4: Global: Point-of-Care Diagnostics Market: Breakup by Platform (in %), 2025
  • Figure 5: Global: Point-of-Care Diagnostics Market: Breakup by Prescription Mode (in %), 2025
  • Figure 6: Global: Point-of-Care Diagnostics Market: Breakup by End-User (in %), 2025
  • Figure 7: Global: Point-of-Care Diagnostics Market: Breakup by Region (in %), 2025
  • Figure 8: Global: Point-of-Care Diagnostics Market Forecast: Sales Value (in Billion USD), 2026-2034
  • Figure 9: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 10: Global: Point-of-Care Diagnostics (Blood-Glucose Monitoring Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 11: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 12: Global: Point-of-Care Diagnostics (Cardio-Metabolic Monitoring Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 13: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 14: Global: Point-of-Care Diagnostics (Pregnancy and Fertility Testing Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 15: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 16: Global: Point-of-Care Diagnostics (Infectious Disease Testing Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 17: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 18: Global: Point-of-Care Diagnostics (Cholesterol Test Strip) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 19: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 20: Global: Point-of-Care Diagnostics (Hematology Testing Kit) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 21: Global: Point-of-Care Diagnostics (Other Product Types) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 22: Global: Point-of-Care Diagnostics (Other Product Types) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 23: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 24: Global: Point-of-Care Diagnostics (Lateral Flow Assays) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 25: Global: Point-of-Care Diagnostics (Dipsticks) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 26: Global: Point-of-Care Diagnostics (Dipsticks) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 27: Global: Point-of-Care Diagnostics (Microfluidics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 28: Global: Point-of-Care Diagnostics (Microfluidics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 29: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 30: Global: Point-of-Care Diagnostics (Molecular Diagnostics) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 31: Global: Point-of-Care Diagnostics (Immunoassays) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 32: Global: Point-of-Care Diagnostics (Immunoassays) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 33: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 34: Global: Point-of-Care Diagnostics (Prescription-Based Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 35: Global: Point-of-Care Diagnostics (OTC Testing) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 36: Global: Point-of-Care Diagnostics (OTC Testing) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 37: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 38: Global: Point-of-Care Diagnostics (Professional Diagnostic Centers) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 39: Global: Point-of-Care Diagnostics (Home Care) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 40: Global: Point-of-Care Diagnostics (Home Care) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 41: Global: Point-of-Care Diagnostics (Research Laboratories) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 42: Global: Point-of-Care Diagnostics (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 43: Global: Point-of-Care Diagnostics (Other End-Users) Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 44: Global: Point-of-Care Diagnostics (Other End-Users) Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 45: North America: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 46: North America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 47: United States: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 48: United States: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 49: Canada: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 50: Canada: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 51: Asia Pacific: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 52: Asia Pacific: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 53: China: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 54: China: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 55: Japan: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 56: Japan: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 57: India: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 58: India: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 59: South Korea: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 60: South Korea: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 61: Australia: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 62: Australia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 63: Indonesia: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 64: Indonesia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 65: Others: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 66: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 67: Europe: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 68: Europe: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 69: Germany: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 70: Germany: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 71: France: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 72: France: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 73: United Kingdom: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 74: United Kingdom: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 75: Italy: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 76: Italy: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 77: Spain: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 78: Spain: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 79: Russia: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 80: Russia: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 81: Others: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 82: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 83: Latin America: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 84: Latin America: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 85: Brazil: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 86: Brazil: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 87: Mexico: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 88: Mexico: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 89: Others: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 90: Others: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 91: Middle East and Africa: Point-of-Care Diagnostics Market: Sales Value (in Million USD), 2020 & 2025
  • Figure 92: Middle East and Africa: Point-of-Care Diagnostics Market Forecast: Sales Value (in Million USD), 2026-2034
  • Figure 93: Global: Point-of-Care Diagnostics Industry: SWOT Analysis
  • Figure 94: Global: Point-of-Care Diagnostics Industry: Value Chain Analysis
  • Figure 95: Global: Point-of-Care Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Point-of-Care Diagnostics Market: Key Industry Highlights, 2025 and 2034
  • Table 2: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Product Type (in Million USD), 2026-2034
  • Table 3: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Platform (in Million USD), 2026-2034
  • Table 4: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Prescription Mode (in Million USD), 2026-2034
  • Table 5: Global: Point-of-Care Diagnostics Market Forecast: Breakup by End-User (in Million USD), 2026-2034
  • Table 6: Global: Point-of-Care Diagnostics Market Forecast: Breakup by Region (in Million USD), 2026-2034
  • Table 7: Global: Point-of-Care Diagnostics Market: Competitive Structure
  • Table 8: Global: Point-of-Care Diagnostics Market: Key Players